Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
183.92
+1.17 (0.64%)
At close: Mar 28, 2025, 4:00 PM
166.25
-17.67 (-9.61%)
After-hours: Mar 28, 2025, 7:57 PM EDT
Krystal Biotech Employees
Krystal Biotech had 275 employees as of December 31, 2024. The number of employees increased by 46 or 20.09% compared to the previous year.
Employees
275
Change (1Y)
46
Growth (1Y)
20.09%
Revenue / Employee
$1,056,418
Profits / Employee
$324,215
Market Cap
5.30B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
KRYS News
- 6 days ago - Krystal Biotech: Preparing To Chase Following Positive CHMP Opinion For VYJUVEK - Seeking Alpha
- 4 weeks ago - Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa - GlobeNewsWire
- 5 weeks ago - Krystal Biotech Soars As Q4 Earnings Put Blockbuster Commercialization In Focus - Seeking Alpha
- 5 weeks ago - Krystal Biotech, Inc. (KRYS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Krystal Biotech Announces Fourth Quarter and Full Year 2024 Financial and Operating Results - GlobeNewsWire
- 5 weeks ago - 20 stocks of companies expected to put up numbers to back investors' new ‘growth mindset' - Market Watch
- 2 months ago - Jeune Aesthetics Appoints Nishant Saxena as Chief Financial Officer - GlobeNewsWire
- 3 months ago - Krystal Biotech: Blockbuster Ambitions For Topical Gene Therapy - Seeking Alpha